Serina Therapeutics, Inc
Price
FilingsNewest: 8-K, Other eventsSep 9 →Insiders4 insiders bought $77,955 in 7 open-market buys. 1 insider sold $501,467, all 29 sales on a 10b5-1 plan.→HoldersSio 3.9%Vanguard 0.6%Waverly 0.3%→Financing →PeersClosest companies: VTGN, CMPX, PMVP→
From the filings
Figures
- Revenue
- $130,000last 12 months
- Net income
- −$21.2Mlast 12 months
- Operating cash flow
- −$18.2Mlast 12 months
- Cash and equivalents
- $23.0Mat the last balance sheet
- Shares outstanding
- 25.4M shareson issue